B-Cell Depletion Therapy Reshapes Antiviral Immunity in Multiple Sclerosis, Study Finds
A cross-sectional study shows that ocrelizumab selectively contracts EBV-specific CD4 T-cell immunity in multiple sclerosis while preserving antiviral defenses against ...
